Squarepoint Ops LLC Cellectar Biosciences, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.8 - $18.2 $1.62 Million - $2.49 Million	-136,942 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.2 - $25.0 $2.08 Million - $3.42 Million	136,942 New	136,942 $220,000
Q4 2020 Feb 16, 2021	SELL	$11.2 - $27.7 $195,832 - $484,334	-17,485 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.6 - $16.6 $68,730 - $107,634	6,484 Added 58.94%	17,485 $22,000
Q2 2020 Aug 14, 2020	BUY	$10.3 - $17.3 $113,310 - $190,317	11,001 New	11,001 $14,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $9.6M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.